Magazine Article | November 1, 2021

The Lasting Impact Of The Pandemic On Pharmacovigilance

Source: Life Science Leader

By Barry Mulchrone & Annette Williams

With COVID-19 again on the rise, the global pandemic continues to impact daily lives and company operations. The pharma sector has seen significant disruption, including how it ensures effective safety monitoring of COVID-19 vaccines and medicines following expedited development and accelerated approvals. Regulators, healthcare professionals, and pharma manufacturers are challenged with real-time reporting and monitoring of emerging safety data for these newly developed vaccines and treatments.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: